Cited by 155T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisHIV Research and Treatment

T follicular helper cells in human efferent lymph retain lymphoid characteristics

Open access
Vella, Laura A., Buggert, Marcus, Manne, Sasikanth, Herati, Ramin S., Sayin, Ismail, Kuri-Cervantes, Leticia, Bukh Brody, Irene, O’Boyle, Kaitlin C. +16 more·2019·Journal of Clinical Investigation

Abstract

T follicular helper cells (Tfh), a subset of CD4+ T cells, provide requisite help to B cells in the germinal centers (GC) of lymphoid tissue. GC Tfh are identified by high expression of the chemokine receptor CXCR5 and the inhibitory molecule PD-1. Although more accessible, blood contains lower frequencies of CXCR5+ and PD-1+ cells that have been termed circulating Tfh (cTfh). However, it remains unclear whether GC Tfh exit lymphoid tissues and populate this cTfh pool. To examine exiting cells, we assessed the phenotype of Tfh present within the major conduit of efferent lymph from lymphoid tissues into blood, the human thoracic duct. Unlike what was found in blood, we consistently identified a CXCR5-bright PD-1-bright (CXCR5BrPD-1Br) Tfh population in thoracic duct lymph (TDL). These CXCR5BrPD-1Br TDL Tfh shared phenotypic and transcriptional similarities with GC Tfh. Moreover, components of the epigenetic profile of GC Tfh could be detected in CXCR5BrPD-1Br TDL Tfh and the transcriptional imprint of this epigenetic signature was enriched in an activated cTfh subset known to contain vaccine-responding cells. Together with data showing shared TCR sequences between the CXCR5BrPD-1Br TDL Tfh and cTfh, these studies identify a population in TDL as a circulatory intermediate connecting the biology of Tfh in blood to Tfh in lymphoid tissue.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci125628

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Activated Tfh express high levels of PD-1 and ICOS, two markers defining the phenotype of Tfh effector cells in secondary lymphoid organs and the efferent lymph.

    “In addition to CXCR5, activated Tfh express high levels of PD-1 and ICOS, two markers defining the phenotype of Tfh effector cells in secondary lymphoid organs (e.g., tonsils) (Figure 8B) and the efferent lymph [143].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 68 · Cited by 155

Research works printed but not linked: 1

  1. ICRP. Report of the Task Group on Reference Man. ICRP Publication 23. Oxford, Pergamon Press; 1975.

Authors
Vella, L. A., Buggert, M., Manne, S., Herati, R. S., Sayin, I., Kuri-Cervantes, L., Bukh Brody, I., O’Boyle, K. C., Kaprielian, H., Giles, J. R., Nguyen, S., Muselman, A., Antel, J. P., Bar-Or, A., Johnson, M. E., Canaday, D. H., Naji, A., Ganusov, V. V., Laufer, T. M., Wells, A. D., Dori, Y., Itkin, M. G., Betts, M. R., & Wherry, E. J.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • Karolinska University Hospital (SE)
  • University of Pennsylvania (US)
  • Parker Institute for Cancer Immunotherapy (US)
  • Montreal Neurological Institute and Hospital (CA)
  • Case Western Reserve University (US)
  • University of Tennessee at Knoxville (US)
  • Philadelphia VA Medical Center (US)
Corresponding author
Wherry, E. John
Venue
Journal of Clinical Investigation
Published
2019-07-02
Volume
129
Issue
8
Pages
3185-3200
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2953645244
Cited by
155
References
68
Citations by year
2026: 13 · 2025: 25 · 2024: 7 · 2023: 17 · 2022: 17 · 2021: 40 · 2020: 29 · 2019: 7
FWCI
9.47
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • NIH (KL2TR001879,P30 AI 045008,GM118553,AI076066,R01 118694,AI105343,AI112521,AI082630,AI117950)
  • Karolinska Institutet (Dnr 537¬2014¬6829)
  • U.S. Department of Veterans Affairs (I01 BX002644)
  • National Institutes of Health (RO1 AI23539)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
T follicular helper cells, efferent lymph, thoracic duct lymph, CXCR5, PD-1, epigenetic signatures, T cell activation, vaccine response, T cell receptor repertoire, lymphocyte migration
MeSH terms
Animals, Female, T-Lymphocytes, Helper-Inducer, Humans, Lymph Nodes, Macaca mulatta, Male, Receptors, Antigen, T-Cell, Thoracic Duct, Receptors, CXCR5, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review